Plasma clearance of intravenous fat emulsion in acute bacterial infections

B Akerlund1, J Nordenström, L Månsson-Morfeldt

  • 1Department of Infectious Diseases, Roslagstulls Hospital, Huddinge University Hospital, Huddinge, Sweden.

A variety of abnormalities in lipid metabolism during infection have been reported and it has been questioned whether intravenous fat emulsion should be given in septic states. This study was designed to investigate the removal of a fat emulsion from plasma during septicaemia. An intravenous fat tolerance test (0.1 g of fat in the form of Intralipid 10% per kg b.w.) was performed in 28 adult patients who had been admitted for suspected septicaemia. All patients were febrile (mean body temperature 38.9 +/- 0.1 degrees C SEM), the majority had leucocytosis (mean value 10.5 +/- 1.0 10 (9)1 ) and all were haemodynamically stable. On the basis of bacterial cultures taken from various locations, the patients were classified as septic (n = 12; gram-negative sepsis, n = 8; gram-positive sepsis, n = 4), infected but without septicaemia (n = 9) or febrile of unknown cause (all cultures negative, n = 7). Plasma fractional removal rates of intravenous fat were similar in the different groups. The mean plasma clearance rate of intravenous fat was 6.6 +/- 0.5 (% minute), which does not differ from that reported for healthy controls. All patients with proven septicaemia and 5 non-septic patients were studied two weeks later when their infection had been treated and they were off antibiotic medication. The plasma clearance rate of i.v. fat was significantly lower in the recovery phase than during the acute febrile state (5.9 +/- 0.5 vs 4.2 +/- 0.4 %/min, n = 17; p < 0.05). It is concluded that clearance of intravenous fat emulsions from plasma is unimpaired in haemodynamically stable patients with septicaemia or other acute infections.

Related Concept Videos

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
Drug Elimination: The Concept of Clearance01:06

Drug Elimination: The Concept of Clearance

Drug elimination refers to removing drugs from the body, either through urine by the kidneys or through bile by the liver. Drug clearance is a pharmacokinetic parameter that measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the plasma concentration of the drug.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
Drug Distribution: Volume of Distribution01:25

Drug Distribution: Volume of Distribution

The volume of distribution refers to the theoretical volume necessary to contain the entire amount of an administered drug at the same concentration observed in the blood plasma. The body's intracellular fluid compartment, which makes up two-thirds of the total body water, is contrasted with the extracellular fluid compartment—comprising plasma and interstitial fluid—that accounts for one-third. The volume of distribution can vary depending on the characteristics of the drug.
Clearance Models: Compartment Models01:25

Clearance Models: Compartment Models

Clearance measures drug elimination from the central compartment, including plasma and highly perfused organs like kidneys and liver. Its calculation varies depending on pharmacokinetic models and administration routes. The one-compartment model, for instance, portrays the pharmacokinetics of polar drugs such as aminoglycoside antibiotics administered intravenously and readily excreted in urine. In this case, clearance is influenced by the terminal rate constant (λz) and the total volume of...
Clearance Models: Noncompartmental Models01:17

Clearance Models: Noncompartmental Models

Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution01:09

One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated from...